Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hematologic Neoplasms 2Sunburn 1Skin Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Mucositis 1Lymphoma 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Cigarette Smoking-Related Carcinoma 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1Brenner Tumor 1Breast Neoplasms 1Arthralgia 1Anatomic Stage I Breast Cancer AJCC v8 1Abnormalities, Radiation-Induced 1

Interventions

pembrolizumab 2Specimen Handling 2Early Intervention, Educational 2pertuzumab 1X-Ray Therapy 1Watchful Waiting 1Trastuzumab 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Protons 1Proton Therapy 1Practice Guidelines as Topic 1Paclitaxel 1Observation 1Motivational Interviewing 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1High-Energy Shock Waves 1Educational Status 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Anatomic Stage I Breast Cancer AJCC v8 × Educational Status × Clear all
NCT06763328 2026-01-22

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

City of Hope Medical Center

Phase 3 Recruiting
200 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡